Berthold, Heiner K., Krone, Wilhelm, Erdmann, Erland and Gouni-Berthold, Ioanna (2011). Lipid lowering in patients with chronic kidney disease: a SHARP turn in the wrong direction? Eur. J. Cardiovasc. Prev. Rehabil., 18 (6). S. 858 - 862. LONDON: SAGE PUBLICATIONS LTD. ISSN 1741-8267

Full text not available from this repository.

Abstract

The question whether lipid-lowering treatment is associated with a decrease in cardiovascular morbidity and mortality in patients with chronic kidney disease has been disputed for a while, with recent trials in patients on haemodialysis failing to show benefit. Recently, the long-awaited results of the SHARP (Study of Heart And Renal Protection) trial were published. This randomized trial compared the effects of either simvastatin 20 mg plus ezetimibe 10 mg daily or placebo on the occurrence of a first major vascular event in 9720 patients with chronic kidney disease. There was a 17% relative risk reduction but no benefit on survival. We address our concerns regarding the conclusions drawn from this trial. The trial has a major design flaw by comparing the effects of two different lipid-lowering drugs with placebo. Although the SHARP trial showed that lipid lowering may be beneficial for patients with chronic kidney disease, the clinically as well as economically important question remains unanswered as to whether it was statin therapy and/or ezetimibe that mediated this effect. A great opportunity to investigate superiority, equipoise, or potential inferiority of ezetimibe compared to statins was missed.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Berthold, Heiner K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Krone, WilhelmUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Erdmann, ErlandUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gouni-Berthold, IoannaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-484240
DOI: 10.1177/1741826711423116
Journal or Publication Title: Eur. J. Cardiovasc. Prev. Rehabil.
Volume: 18
Number: 6
Page Range: S. 858 - 862
Date: 2011
Publisher: SAGE PUBLICATIONS LTD
Place of Publication: LONDON
ISSN: 1741-8267
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
PLACEBO-CONTROLLED TRIAL; CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; LDL CHOLESTEROL; SIMVASTATIN; ATORVASTATIN; EZETIMIBE; HEMODIALYSISMultiple languages
Cardiac & Cardiovascular SystemsMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/48424

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item